Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACSL1 | P33121 | 2/20 | 0.54 |
| ▸ | ACSL6 | Q9UKU0 | 2/20 | 0.54 |
| ▸ | MAOA | P21397 | 3/20 | 0.47 |
| ▸ | MAOB | P27338 | 3/20 | 0.47 |
| ▸ | PLA2G4B | P0C869 | 5/20 | 0.47 |
| ▸ | ALDH2 | P05091 | 2/20 | 0.46 |
| ▸ | LTB4R | Q15722 | 2/20 | 0.45 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.44 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.44 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.44 |
| ▸ | GPR17 | Q13304 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6270759 | 1.00 | ACSL1 (0.54) | ACSL1ACSL6MAOAMAOBPLA2G4B | |
| SCHEMBL6277207 | 0.98 | ACSL1 (0.57) | ACSL1ACSL6MAOAMAOBPLA2G4B | |
| SCHEMBL6275180 | 0.98 | ACSL1 (0.57) | ACSL1ACSL6MAOAMAOBPLA2G4B | |
| SCHEMBL27563415 | 0.97 | ACSL1 (0.58) | ACSL1ACSL6MAOAMAOBPLA2G4B | |
| SCHEMBL6277212 | 0.97 | ACSL1 (0.53) | ACSL1ACSL6MAOAMAOBPLA2G4B | |
| SCHEMBL6277120 | 0.96 | ACSL1 (0.52) | ACSL1ACSL6MAOAMAOBPLA2G4B | |
| SCHEMBL6277135 | 0.96 | ACSL1 (0.52) | ACSL1ACSL6MAOAMAOBPLA2G4B | |
| SCHEMBL6276243 | 0.96 | ACSL1 (0.57) | ACSL1ACSL6MAOAMAOBPLA2G4B | |
| SCHEMBL6274684 | 0.92 | ACSL1 (0.50) | ACSL1ACSL6MAOAMAOBPLA2G4B | |
| SCHEMBL6270807 | 0.92 | ALDH2 (0.53) | ACSL1ACSL6MAOAMAOBPLA2G4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1273578-B1 | Benzopyran derivatives and antiallergic agent containing the same | DAINIPPON INK & CHEMICALS (JP) | 2005-02-23 | — | — | EP | disclosed |
| CN-1473565-A | Benzopyrany/derivatives and antiallergic agent | ���ձ���ī��ѧ��ʽ���� | 2004-02-11 | — | — | CN | disclosed |
| US-6670391-B2 | For inhibiting both immediate and delayed type allergic reactions; side effect reduction | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-12-30 | — | — | US | disclosed |
| US-20030096860-A1 | Benzopyran derivative and antiallergic agent | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-05-22 | — | — | US | disclosed |
| EP-1273578-A1 | Benzopyran derivatives and antiallergic agent containing the same | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-01-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030096860-A1 | Benzopyran derivative and antiallergic agent | HRH2, HRH1, HRH4 | ACSL1 1912/4885ACSL6 2711/4885MAOA 665/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.